Jessica Nave, MD, vice president for middle revenue cycle at Emory Healthcare and assistant professor of medicine in Emory’s division of hospital medicine, both in Atlanta, summarized the updated 2025 ...

Data from EULAR 2026 show that next-generation CAR T- and NK cell platforms induce powerful, drug-free clinical remissions in patients with highly refractory rheumatic diseases.